Tired – that was yesterday!*
The vegan iron prepartions Cefavit® ferrit supply important nutrients for the energy-yielding metabolism and thus, for energy and against tiredness*. Thereby, the contained iron compounds (ferrous-II-bisglycinate and microencapsulated ferrous-II-fumarate) are very well tolerated and bioavailable [1,2].
Within the human body, iron supports numerous essential functions: It is involved in the energy-yielding metabolism and furthermore, it is a component of hundreds of enzymes, having varied tasks. As a result, an undersupply with iron can be shown by means of many symptoms. However, most conspicuous are tiredness and symptoms of exhaustion.
- iron with good tolerability and high bioavailability
- reasonably combined with nutrients for iron metabolism and blood formation*
- NEW: also available as Stix
Cefavit® ferrit Stix
- 14 mg iron per Stix
- iron-II-fumarate, microencapsulated
- direct intake without any liquid, ideal for on the go
- taste of blackcurrant
Cefadirect® tastes great
- 14 mg iron per capsule
- iron-II-bisglycinate: well tolerated, highly bioavailable 
- reasonably combined
for normal formation of haemoglobin (hb) and for normal oxygen transport
iron, vitamins B2/B6/B12
for maintenance resp. normal formation of normal red blood cells
iron, vitamins C/B2/B6/B12
for normal energy-yielding metabolism
iron, vitamins C/B2/B6/B12, folate
for reduction of tiredness and fatigue
for normal blood formation
increases iron absorption
for normal metabolism of iron
Additionally in capsules: copper
for normal iron transport and for normal energy-yielding metabolism
Food supplements should not be used as substitution for a balanced and varied nutrition and for a healthy way of life. The mentioned quantity, recommended for the daily intake, must not be exceeded. Not intended for children, adolescents and persons with iron storage diseases. For men, postmenopausal and pregnant women, the consultation with the therapist is recommended.
Additionally for Stix: Can have a laxative effect in case of overuse.
 EFSA Journal (2006) 299, 1-17
 Patil et al. AJMS. 2013;6(1):29-33